Panagora Asset Management’s National Healthcare NHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4,691
| Closed | -$300K | – | 1268 |
|
|
2023
Q3 | $300K | Sell |
4,691
-2,633
| -36% | -$169K | ﹤0.01% | 1074 |
|
|
2023
Q2 | $453K | Sell |
7,324
-1,019
| -12% | -$60.4K | ﹤0.01% | 1000 |
|
|
2023
Q1 | $484K | Buy |
8,343
+147
| +2% | +$8.45K | ﹤0.01% | 1132 |
|
|
2022
Q4 | $488K | Buy |
+8,196
| New | +$497K | ﹤0.01% | 1166 |
|
|
2022
Q3 | – | Sell |
-9,965
| Closed | -$697K | – | 1508 |
|
|
2022
Q2 | $697K | Hold |
9,965
| – | – | ﹤0.01% | 1038 |
|
|
2022
Q1 | $700K | Buy |
9,965
+593
| +6% | +$39.9K | ﹤0.01% | 1090 |
|
|
2021
Q4 | $637K | Hold |
9,372
| – | – | ﹤0.01% | 1115 |
|
|
2021
Q3 | $656K | Hold |
9,372
| – | – | ﹤0.01% | 1180 |
|
|
2021
Q2 | $655K | Buy |
9,372
+27
| +0.3% | +$1.96K | ﹤0.01% | 1212 |
|
|
2021
Q1 | $728K | Sell |
9,345
-7,902
| -46% | -$559K | ﹤0.01% | 1153 |
|
|
2020
Q4 | $1.15M | Buy |
17,247
+8,315
| +93% | +$548K | 0.01% | 918 |
|
|
2020
Q3 | $557K | Buy |
8,932
+3,176
| +55% | +$199K | ﹤0.01% | 1118 |
|
|
2020
Q2 | $365K | Sell |
5,756
-1,784
| -24% | -$120K | ﹤0.01% | 1317 |
|
|
2020
Q1 | $541K | Buy |
7,540
+998
| +15% | +$78.9K | ﹤0.01% | 1086 |
|
|
2019
Q4 | $565K | Sell |
6,542
-2,067
| -24% | -$173K | ﹤0.01% | 1260 |
|
|
2019
Q3 | $705K | Sell |
8,609
-820
| -9% | -$67.9K | ﹤0.01% | 1165 |
|
|
2019
Q2 | $765K | Sell |
9,429
-44,005
| -82% | -$3.4M | ﹤0.01% | 1264 |
|
|
2019
Q1 | $4.05M | Buy |
53,434
+15,066
| +39% | +$1.2M | 0.02% | 574 |
|
|
2018
Q4 | $3.01M | Sell |
38,368
-3,165
| -8% | -$248K | 0.01% | 616 |
|
|
2018
Q3 | $3.13M | Sell |
41,533
-604
| -1% | -$44.4K | 0.01% | 679 |
|
|
2018
Q2 | $2.97M | Buy |
42,137
+8,951
| +27% | +$586K | 0.01% | 730 |
|
|
2018
Q1 | $1.98M | Buy |
33,186
+32,286
| +3,587% | +$1.98M | 0.01% | 879 |
|
|
2017
Q4 | $55K | Hold |
900
| – | – | ﹤0.01% | 2032 |
|
|
2017
Q3 | $56K | Hold |
900
| – | – | ﹤0.01% | 2033 |
|
|
2017
Q2 | $63K | Hold |
900
| – | – | ﹤0.01% | 2013 |
|
|
2017
Q1 | $64K | Hold |
900
| – | – | ﹤0.01% | 1962 |
|
|
2016
Q4 | $68K | Hold |
900
| – | – | ﹤0.01% | 2035 |
|
|
2016
Q3 | $59K | Hold |
900
| – | – | ﹤0.01% | 2089 |
|
|
2016
Q2 | $58K | Hold |
900
| – | – | ﹤0.01% | 2030 |
|
|
2016
Q1 | $56K | Hold |
900
| – | – | ﹤0.01% | 1995 |
|
|
2015
Q4 | $56K | Hold |
900
| – | – | ﹤0.01% | 1947 |
|
|
2015
Q3 | $55K | Sell |
900
-66
| -7% | -$4.13K | ﹤0.01% | 1970 |
|
|
2015
Q2 | $63K | Hold |
966
| – | – | ﹤0.01% | 2086 |
|
|
2015
Q1 | $62K | Hold |
966
| – | – | ﹤0.01% | 2045 |
|
|
2014
Q4 | $61K | Sell |
966
-1,583
| -62% | -$95.1K | ﹤0.01% | 1984 |
|
|
2014
Q3 | $141K | Hold |
2,549
| – | – | ﹤0.01% | 1743 |
|
|
2014
Q2 | $143K | Buy |
2,549
+1,583
| +164% | +$86.2K | ﹤0.01% | 1831 |
|
|
2014
Q1 | $54K | Hold |
966
| – | – | ﹤0.01% | 2077 |
|
|
2013
Q4 | $52K | Hold |
966
| – | – | ﹤0.01% | 1979 |
|
|
2013
Q3 | $46K | Hold |
966
| – | – | ﹤0.01% | 2034 |
|
|
2013
Q2 | $46K | Buy |
+966
| New | +$45.1K | ﹤0.01% | 2041 |
|
Other funds holding NHC
Panagora Asset Management's NHC Position: Q4 2023 in Review
Panagora Asset Management sold out of National Healthcare (NHC) in Q4 2023, closing a stake of 4,691 shares — an estimated $300K sold.
Panagora Asset Management first reported a position in NHC in Q2 2013 and held it in 41 quarters. The position peaked at $4.05M in Q1 2019. 159 funds tracked by Wall St. Rank hold NHC as of Q4 2023.
- Panagora Asset Management reported no remaining National Healthcare position as of Q4 2023 after selling out during the quarter.
- Panagora Asset Management sold 4,691 National Healthcare shares in Q4 2023, an estimated $300K.
- Panagora Asset Management first reported a position in National Healthcare in Q2 2013 and held it in 41 quarters.
- Panagora Asset Management's National Healthcare position peaked at $4.05M in Q1 2019.
- 159 funds tracked by Wall St. Rank held National Healthcare as of Q4 2023.
Based on Panagora Asset Management's 13F filing for Q4 2023, filed 8 Feb 2024.